What Happens if I'm Eligible?
All enrolled participants have an equal chance of being randomly assigned to one of three study groups that will vary by therapy focus/content and dosage. They are:
- The investigational intervention, Accelerated Skill Acquisition Program (ASAP): 30 visits of an individualized therapy focused on the arm most affected by the stroke. This is an integrated and evidence-based intervention for upper extremity recovery that arose from diverse but converging and complementary and interdisciplinary literatures of basic and applied science as well as recent translational and clinical trials research of upper extremity recovery after stroke. Unique aspects include the structured framework by which intensity and progression of practice is managed and by which participant skills and confidence are fostered through therapist-patient dialogue. sustained a stroke within the last 3 months
- A dose-equivalent (30 visits) of usual and customary outpatient arm therapy (DEUCC): 30 visits scheduled 3x/week over 10 weeks Usual and customary outpatient arm therapy care (UCC): delivered at the dosage common for that outpatient setting. This will vary by site but is likely to be less than 30 visits, and in some cases, may be no therapy.
- Regardless of study group all participants will receive comprehensive evaluations up to 1-year and may receive therapy in the outpatient setting provided by licensed/certified occupational therapists (OT), and physical therapists (PT).

